![](/img/cover-not-exists.png)
A phase III trial of exemestane plus bevacizumab maintenance therapy in patients with metastatic breast cancer after first-line taxane and bevacizumab: a GINECO group study
Trédan, O., Follana, P., Moullet, I., Cropet, C., Trager-Maury, S., Dauba, J., Lavau-Denes, S., Diéras, V., Béal-Ardisson, D., Gouttebel, M., Orfeuvre, H., Stefani, L., Jouannaud, C., Bürki, F., PetitLanguage:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw077
Date:
February, 2016
File:
PDF, 664 KB
english, 2016